SMS Pharmaceuticals completes USFDA inspection at Central Laboratory Analytical Services
Drug Approval

SMS Pharmaceuticals completes USFDA inspection at Central Laboratory Analytical Services

The inspection concluded with zero Form 483 observations

  • By IPP Bureau | June 27, 2025

SMS Pharmaceuticals Limited has announced the second successful completion of the United States Food and Drug Administration (USFDA) inspection at our Central Laboratory Analytical Services, located at, Gagillapur Village, Medchal Malkajgiri District, Hyderabad, Telangana.

The inspection, conducted from 23rd June 2025 to 25th June 2025, concluded with zero Form 483 observations.

The company is committed to meeting the highest quality standards and is further committed to full compliance with CGMP & GLP regulations at all our manufacturing & Analytical facilities. The "Central Laboratory Analytical Services" is our independent testing laboratory, and this was the second successful USFDA inspection for the facility.

Upcoming E-conference

Other Related stories

Startup

Digitization